KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The acquisition of mcePharma, a company focused on the development and production of innovative food supplements, complementary pet feed, and cosmetics, represents a strategic step for the Brenntag Group to strengthen its presence in the Life Sciences market in the EMEA region.
This was already the second successful sale of a company managed by Mr. Mikeš – we previously represented him in the sale of IMCoPharma to the Barentz Group.
Other articles
When too much prevention does more harm than good
At the end of 2025, the Supreme Court of the Czech Republic ruled that the preventive retention of traffic and location data under the Electronic Communications Act infringes the rights of the persons whose data is concerned.
KŠB Advises on the Establishment of FIDUROCK Retail Parks Fund SICAV
Kocián Šolc Balaštík advised Fidurock on the establishment of FIDUROCK Retail Parks Fund SICAV, an investment fund targeting qualified investors and focused on areal estate portfolio in the Czech Republic and Slovakia.
KŠB Announces Senior Appointments: Ivo Průša Named Partner; Dana Jacková, Jana Guričová and Ján Béreš Promoted to Counsel
Kocián Šolc Balaštík (KŠB) has recently made several senior appointments within its leadership team. Ivo Průša has been named Partner as of 1 January 2026, while Dana Jacková, Jana Guričová and Ján Béreš have been promoted to the position of Counsel.
